SCHEMBL6569559

SCHEMBL6569559

C=COC1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 2/20 0.72
POLA1 P09884 1/20 0.71
OSBP P22059 6/20 0.70
RORC P51449 4/20 0.70
OSBP2 Q969R2 3/20 0.70
USP2 O75604 2/20 0.70
LMNA P02545 1/20 0.70
ABCB1 P08183 1/20 0.70
GRIN1 Q05586 4/20 0.60
GRIN2A Q12879 4/20 0.60
NR1H3 Q13133 5/20 0.60
GBA1 P04062 2/20 0.59
UGCG Q16739 2/20 0.59
GBA2 Q9HCG7 2/20 0.59
GRIN2B Q13224 3/20 0.58
NPC1L1 Q9UHC9 2/20 0.57
CRYAB P02511 1/20 0.57
HMGCR P04035 1/20 0.57
ITGB3 P05106 1/20 0.57
ITGAV P06756 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21707462 1.00 CYP46A1 (0.72) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL21741490 1.00 CYP46A1 (0.72) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL728697 1.00 CYP46A1 (0.72) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL728696 1.00 CYP46A1 (0.72) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL1369754 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL21935259 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL22523945 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL7989828 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL18627850 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2
SCHEMBL1045464 0.91 CYP46A1 (0.75) CYP46A1POLA1OSBPRORCOSBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed